UNTOWARD EFFECTS FROM THE USE OF ERGOT AND ERGOTAMINE TARTRATE
Authors: Mandred W. Comfort, Clarence W. Erickson
Journal: Annals of Internal Medicine (1939)

Article1 July 1939UNTOWARD EFFECTS FROM THE USE OF ERGOT AND ERGOTAMINE TARTRATEMANDRED W. COMFORT, M.D., F.A.C.P., CLARENCE W. ERICKSON, M.D.MANDRED W. COMFORT, M.D., F.A.C.P.Search for more papers by this author, CLARENCE W. ERICKSON, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-13-1-46 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptErgot preparations have enjoyed a time-honored place in obstetrical practice. In properly standardized dosage they have come to be accepted as useful oxytocics when administered after expression of the placenta; they promote uterine involution and prevent postpartum bleeding and puerperal sepsis. Since isolation of the crystalline alkaloid, ergotamine, described by Spiro and Stoll1in 1921, numerous clinical entities have been treated by the specific ergot alkaloids. At one time in the past decade, approximately 80 medical disorders of one kind or another were enthusiastically treated with ergotamine tartrate. Peptic ulcer, migraine, pruritus, diabetes mellitus and insipidus, hyperthyroidism, glaucoma, various hemorrhagic...References1. SPIROSTOLL KA: Ueber die wirksamen Substanzen des Mutterkorns, Schweiz. med. Wchnschr., 1921, li, 525-529. Google Scholar2. FARRARDUFF GEAM: Ergotamine tartrate: its direct hyperglycemic action and its influence on the hyperglycemia produced by epinephrine in normal unanesthetized dogs, Jr. Pharmacol., 1928, xxxiv, 197-202. YOUMANS, J. B., and TRIMBLE, W. H.: Experimental and clinical studies of ergotamine. I. Effect of ergotamine on the blood sugar and epinephrine hyperglycemia in trained unanesthetized dogs, Jr. Pharmacol. and Exper. Therap., 1930, xxxviii, 121-132. II. The effect of ergotamine on the heart rate of trained, unanesthetized dogs, Jr. Pharmacol. and Exper. Therap., 1930, xxxviii, 133-144. III. The effect of ergotamine on the oxygen consumption of normal, trained dogs, Jr. Pharmacol. and Exper. Therap., 1930, xxxix, 201-208. YOUMANS, J. B., TRIMBLE, W. H., and FRANK, HELEN: Experimental and clinical studies of ergotamine. IV. The effect of ergotamine on the basal metabolism, circulation and blood sugar of normal persons and of patients with thyrotoxicosis, Arch. Int. Med., 1931, xlvii, 612-632. YOUMANS, J. B., TRABUE, CHARLES, BUVINGER, R. S., and FRANK, HELEN: Experimental and clinical studies of ergotamine. V. The action of ergotamine on the sympathetic nervous system stimulated by epinephrine. Studies of the metabolic rate, pulse rate, blood pressure, blood sugar and the total leukocyte count, ANN. INT. MED., 1933, vii, 653-663. LAWRENCE, R. D.: The effect of ergotamine on carbohydrate metabolism and on the stomach, Brit. Jr. Exper. Path., 1930, xi, 145-148. Google Scholar3. LENNOXVON STORCH WGTJ: Experience with ergotamine tartrate in 120 patients with migraine, Jr. Am. Med. Assoc., 1935, cv, 169-171. LENNOX, W. G., and LEONHARDT, HILDEGARDE C.: The flow and concentration of blood as influenced by ergot alkaloids and as influencing migraine, ANN. INT. MED., 1937, xi, 663-670. CrossrefGoogle Scholar4. LICHTMAN SS: Therapeutic response to ergotamine tartrate in pruritus of hepatic and renal origin, Jr. Am. Med. Assoc., 1931, xcvii, 1463-1464. SNELL, A. M., and KEYS, H. C.: Pruritus of jaundiced patients: its incidence and treatment, Med. Clin. N. Am., 1933, xvi, 1455-1470. CrossrefGoogle Scholar5. BARGERCARR GFN: Quoted by Barger, George. Google Scholar6. DALESPIRO HHK: Die wirksamen Alkaloide des Mutterkorns, Arch. f. exper. Path. u. Pharmakol., 1922, xcv, 337-350. BURN, J. H., and ELLIS, J. M.: Quoted by Barger, George. LOZINSKI, E., HOLDEN, G. W., and DIVER, G. R.: The relative activity of ergotoxine and ergotamine, Jr. Pharmacol. and Exper. Therap., 1931, xlii, 123-131. VARTIAINEN, A.: The action of ergoclavine and sensibamine, Jr. Pharmacol. and Exper. Therap., 1935, liv, 259-264. CrossrefGoogle Scholar7. BARGERDALE GHH: Ergotoxine and some other constituents of ergot, Biochem. Jr., 1907, ii, 240-299. CrossrefGoogle Scholar8. WOODLA WALL HCCH: The dispensatory of the United States of America. Ergota., 1937, Ed. 22, J. B. Lippincott Company, Philadelphia, p. 432. Google Scholar9. POOLNASON JLGI: Cerebral circulation: XXXV. The comparative effect of ergotamine tartrate on the arteries in the pia, dura and skin of cats, Arch. Neurol. and Psychiat., 1935, xxxiii, 276-282. CrossrefGoogle Scholar10. RIGLERSILBERSTERN RE: Über die Temperatursenkende Wirkung des Ergotamins, Klin. Wchnschr., 1926, v, 1831. CrossrefGoogle Scholar11. ABRAMSONLICHTMAN DISS: Influence of ergotamine tartrate upon peripheral blood-flow in subjects with liver disease, Proc. Soc. Exper. Biol. and Med., 1937, xxxvii, 262-267. CrossrefGoogle Scholar12. WILLIAMS DH: Personal communication to the authors. Google Scholar13. BARGER G: Ergot and ergotism, 1931, Gurney and Jackson, London, 279 pp. Google Scholar14. STOCKMAN R: The cause of convulsive ergotism, Jr. Hyg., 1934, xxxiv, 235-241. CrossrefGoogle Scholar15. OLDRIGHT GS: Quoted by Hulme, Laure. Google Scholar16. MEADOWS J: Quoted by Hulme, Laure. Google Scholar17. KEATING JM: Ergot-poisoning, Med. Rec., 1880, xviii, 318-319. The toxic action of ergot, Med. Rec., 1880, xviii, 558-559. Google Scholar18. HULME L: Case of acute ergotism occurring after the ingestion of a fluidounce of the fluid extract of ergot, Med. News, 1887, li, 538-540. Google Scholar19. MOSKOWITZ HL: Report of a case of ergot poisoning postpartum, Am. Jr. Obst. and Gynec., 1928, xv, 549-552. CrossrefGoogle Scholar20. DAVIDSON A: Fatal case of poisoning by ergot of rye, Lancet, 1882, ii, 526-527. CrossrefGoogle Scholar21. KOBERT R: Ueber die Bestandtheile und Wirkungen des Mutterkorns, Arch. f. exper. Path. u. Pharmakol., 1884, xviii, 316-380. CrossrefGoogle Scholar22. MCKAY WJ: Gangrene of the fingers following the administration of liquid ergot, Brit. Med. Jr., 1906, ii, 365. Google Scholar23. ROSENBLOOMSCHILDECKER JCB: The successful isolation of ergotinin crystals from certain organs in a case of acute ergot poisoning, Jr. Am. Med. Assoc., 1914, lxiii, 1203-1204. CrossrefGoogle Scholar24. SAENGER H: Über Puerperalgangrän bei septischen Zuständen und Gynergenmedikation, Zentralbl. f. Gynäk., 1929, liii, 586-594. Google Scholar25. OGINZ P: Ergotismus gangrenosus, Am. Jr. Obst. and Gynec., 1930, xix, 657-664. CrossrefGoogle Scholar26. ROCH M: Ergotisme gangreneux, Presse méd., 1935, xliii, 31-32. Google Scholar27. POLANO O: Quoted by Saenger, Hans. Google Scholar28. BRACK W: Über den Unterschied zwischen normalem und abnormen Ansprechen auf Ergotamin, Belladonna und Scopolamin, Klin. Wchnschr., 1929, viii, 1652-1655. CrossrefGoogle Scholar29. SCHÖNBAUER L: Zur Behandlung des Morbus Basedow mit Ergotamin (Gynergen), Deutsch. Ztschr. f. Chir., 1926, cxcviii, 99-100. CrossrefGoogle Scholar30. PLATT R: Über die Behandlung des Morbus Basedow mit Ergotamin, Klin. Wchnschr., 1930, ix, 258-261. CrossrefGoogle Scholar31. SPECK W: Gefahr des Mutterkornbrandes bei Anwendung von Gynergen (Sandoz) in der Basedow-Chirurgie, Med. Klin., 1930, ii, 1521-1523. Google Scholar32. ZORN D: Gynergenschädigung und ihre Beseitigung durch Wechselfussbäder und Padutin, Deutsch. med. Wchnschr., 1931, ii, 1978-1979. Google Scholar33. MÜLLER K: Zur Frage der Behandlung des Morbus Basedowii mit Ergotamin, München. med. Wchnschr., 1933, ii, 1784-1786. Google Scholar34. YATERCAHILL WMJA: Bilateral gangrene of feet due to ergotamine tartrate used for pruritus of jaundice: report of a case studied arteriographically and pathologically, Jr. Am. Med. Assoc., 1936, cvi, 1625-1631. CrossrefGoogle Scholar35. GOULDPRICEGINSBERG SEAEHI: Gangrene and death following ergotamine tartrate (gynergen) therapy, Jr. Am. Med. Assoc., 1936, cvi, 1631-1635. CrossrefGoogle Scholar36. PERLOWBLOCH SL: Impending gangrene of the feet due to ergotamine tartrate: report of a case treated successfully, Jr. Am. Med. Assoc., 1937, cix, 27-28. CrossrefGoogle Scholar37. LABBÉBOULINJUSTIN-BESANçONGOUYEN MR: L'angine de poitrine ergotaminique, Presse méd., 1929, ii, 1069. Google Scholar38. ZIMMERMANN O: Störung der Coronardurchblutung durch Ergotamin, Klin. Wchnschr., 1935, xiv, 500-503. CrossrefGoogle Scholar39. PANTER H: Tabische Symptome nach Gynergen-Injektionen, Med. Klin., 1926, i, 880-881. Google Scholar40. BABERTIETZ EAEB: The effect of ergotamine tartrate on the behavior of psychotic patients, Jr. Med., 1937, xvii, 551-557. Google Scholar41. GAYSINOVICHKENIGSBERGKOGAN SEA: Symptoms and prophylaxis of ergotism, Vrachebnoe Dielo, Kharkov., 1934, xvii, 433. Abst., Jr. Am. Med. Assoc., 1935, civ, 167. Google Scholar42. CAFFIER P: Streptokokkeninfektion und Sekalepräparate, Zentralbl. f. Gynäk., 1928, lii, 1953-1965. Google Scholar43. LEWISGELFAND TB: The manner in which necrosis arises in the fowl's comb under ergot poisoning, Clin. Sci., 1935, ii, 43-55. Google Scholar44. RUBINRAPOPORT MIM: Effect of magnesium on vascular spasm in rats. Arch. Int. Med., 1937, lix, 714-723. CrossrefGoogle Scholar45. HORTONROTHADSON BTGMAW: Observations on some differences in the vasomotor reactions of the hands and feet, Proc. Staff Meet. Mayo Clinic, 1936, xi, 435-437. Google Scholar46. ALLENMACLEAN EVAR: Treatment of sudden arterial occlusion with papaverin hydrochloride: report of case, Proc. Staff Meet. Mayo Clinic, 1935, x, 216-220. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Rochester, Minnesota*Submitted for publication April 28, 1938. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byErgotamine Toxicity and Serum Concentrations of Ergotamine in Migraine PatientsHAS THE CHANGE TO BETA-AGONISTS COMBINED WITH ORAL THEOPHYLLINE INCREASED CASES OF FATAL ASTHMA?THE HEPATOTOXICITY OF ERGOT ALKALOIDSErgotaminismToxicologic ConsiderationsErgot poisoning in acute hepatic necrosis.ACUTE ERGOTISM: REPORT OF A CASE AND A REVIEW OF THE LITERATUREKrankheiten der GefäßeIntoxikationenAtrio-ventricular Block after GynergenTreatment of MigraineVarieties of Digital Ischemia and Their ManagementImpending gangrene of the foot following treatment for pruritus of jaundice with ergotamine tartrate: Report of caseBilateral dry gangrene bofboth lower extremities due to ergot 1 July 1939Volume 13, Issue 1Page: 46-60KeywordsAlkaloidsDiabetes mellitusGlaucomaHemorrhageHyperthyroidismMigrainePeptic ulcersPlacentaPruritusSepsis ePublished: 1 December 2008 Issue Published: 1 July 1939 PDF downloadLoading ...